We are live on ! Find out more
NTRP

Neurotrope, Inc. Common
NTRP

Delisted

NTRP was delisted on the 1st of December, 2020.

23 hedge funds and large institutions have $5.07M invested in Neurotrope, Inc. Common in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $311K | Put options by funds: $143K

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

15% less funds holding

Funds holding: 2723 (-4)

44% less capital invested

Capital invested by funds: $9M → $5.07M (-$3.93M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
4
Closed
6
Calls
$311K
Puts
$143K
Net Calls
+$168K
Net Calls Change
-$209K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
-$55K -5,825 Closed
Deutsche Bank
27
Deutsche Bank
Germany
-$8K -900 Closed
Creative Planning
28
Creative Planning
Kansas
-$1K -80 Closed
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
+$5 +1 New

NTRP Hedge Fund Activity: Q3 2017 in Review

23 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q3 2017, worth a combined $5.07M — down 44% from $9M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NTRP and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 8 added.

The largest buyer was JP Morgan Private Wealth Advisors, adding an estimated $157K. The largest seller was Spark Investment Management, exiting entirely with an estimated $214K sold.

  • 23 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q3 2017, down from 27 in Q2 2017.
  • Funds reported $5.07M of Neurotrope, Inc. Common stock for Q3 2017, down 44% quarter-over-quarter.
  • 3 funds opened new Neurotrope, Inc. Common positions in Q3 2017 and 6 closed out, a net change of -3 holders.
  • The largest Neurotrope, Inc. Common buyer in Q3 2017 was JP Morgan Private Wealth Advisors, an estimated $157K added.
  • The largest Neurotrope, Inc. Common seller in Q3 2017 was Spark Investment Management, an estimated $214K sold.

Based on aggregated 13F filings for Q3 2017.